Intensified glucose lowering in type 2 diabetes: time for a reappraisal
- 5 August 2010
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 53 (10), 2079-2085
- https://doi.org/10.1007/s00125-010-1864-z
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 DiabetesNew England Journal of Medicine, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Prevalence of comorbidity of chronic diseases in AustraliaBMC Public Health, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990